A, F. M., F, V. R., N, M. L., M, C. R., A, C. C., P, G. V., . . . J, G. G. (2020). Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: Patterns of use and prognostic nomogram. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 22(3), 351. https://doi.org/10.1007/s12094-019-02130-x
Chicago Style (17th ed.) CitationA, Fernandez Montes, et al. "Efficacy and Safety of Trifluridine/tipiracil in Third-line and Beyond for the Treatment of Patients with Metastatic Colorectal Cancer in Routine Clinical Practice: Patterns of Use and Prognostic Nomogram." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22, no. 3 (2020): 351. https://doi.org/10.1007/s12094-019-02130-x.
MLA (9th ed.) CitationA, Fernandez Montes, et al. "Efficacy and Safety of Trifluridine/tipiracil in Third-line and Beyond for the Treatment of Patients with Metastatic Colorectal Cancer in Routine Clinical Practice: Patterns of Use and Prognostic Nomogram." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 22, no. 3, 2020, p. 351, https://doi.org/10.1007/s12094-019-02130-x.
